Will nonobstructing kidney stones pass on their own?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Will Nonobstructing Kidney Stones Pass?

Yes, most nonobstructing kidney stones will pass spontaneously, but the likelihood depends critically on stone size and location—stones <5 mm pass in 68-89% of cases, while stones 5-10 mm pass in only 47-62% of cases. 1

Stone Passage Rates by Size and Location

Stones <5 mm

  • Spontaneous passage occurs in 68-75% of cases overall 1
  • Distal ureteral stones <5 mm pass in 89% of cases 1
  • Upper ureteral stones <5 mm pass in 75% of cases 1
  • Average time to passage is 8-17 days 1, 2
  • For 95% of stones ≤2 mm to pass, it takes approximately 31 days 2

Stones 5-10 mm

  • Spontaneous passage drops to 47-62% overall 1
  • Distal stones 5-10 mm have higher passage rates than proximal stones 1
  • Average time to passage extends to 12-40 days depending on exact size 2
  • Medical expulsive therapy with alpha-blockers increases passage rates by an absolute 22-29% 3

Stones >10 mm

  • Spontaneous passage is unlikely and intervention should be considered 1, 3
  • These stones have low passage rates and high complication risk 3

Location-Specific Passage Rates

Stone location significantly predicts spontaneous passage and symptom development: 4, 2

  • Distal ureteral stones: 68-83% passage rate 1
  • Mid ureteral stones: 58-70% passage rate 1
  • Upper ureteral stones: 49-52% passage rate 1
  • Lower pole renal stones are significantly less likely to pass (2.9%) compared to upper/mid pole stones (14.5%) 4

Natural History of Nonobstructing Renal Stones

For asymptomatic nonobstructing renal calculi managed with observation: 4

  • Most (72%) remain asymptomatic through average 3+ year follow-up 4
  • Less than 30% develop renal colic 4
  • Only 7% pass spontaneously 4
  • Upper/mid pole stones are more likely to become symptomatic (40.6%) than lower pole stones (24.3%) 4

Critical Pitfall: Silent Obstruction

A small but important subset (2-3%) of asymptomatic nonobstructing stones can cause painless silent obstruction requiring intervention after an average of 37 months. 4 This underscores the need for regular follow-up imaging even in asymptomatic patients to prevent renal loss.

Medical Expulsive Therapy Considerations

For distal ureteral stones 5-10 mm, tamsulosin 0.4 mg daily increases stone passage rates to 81-87% compared to 61-79% with placebo. 3

  • Number needed to treat is 4-5 patients 3
  • Reduces time to stone expulsion by approximately 3 days 3
  • Should be discontinued if infection, refractory pain, or declining renal function develops 1, 3
  • Maximum conservative management period is 4-6 weeks to avoid irreversible kidney injury 1, 3

When Observation is Inappropriate

Observation alone is inappropriate for nonobstructing stones when: 1

  • Stone demonstrates growth on serial imaging 1
  • Patient has high risk of stone formation 1
  • Infection or sepsis is present 1, 3
  • Declining renal function occurs 1, 3
  • Refractory pain despite adequate analgesia 1, 3

Intervention Thresholds

Active intervention should be offered when: 1

  • Stones >10 mm (low spontaneous passage rates) 1, 3
  • Failed conservative management after 4-6 weeks 1, 3
  • Development of complications (infection, obstruction, declining renal function) 1, 3
  • Patient preference after informed discussion of risks/benefits 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tamsulosin for Kidney Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.